ML-236A, ML-236B, and ML-236C, new inhibitors of c...[J Antibiot (Tokyo). 1976] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search (beta)

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: J Antibiot (Tokyo). 1976 Dec;29(12):1346-8.Links

ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium.

Endo A, Kuroda M, Tsujita Y.

PMID: 1010803 [PubMed - indexed for MEDLINE]

Related Articles

Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. [Eur J Biochem. 1977]
The effect of compactin, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme-A reductase activity, on cholesterogenesis and serum cholesterol levels in rats and chicks. [Atherosclerosis. 1980]
Compactin (ML-236B) and related compounds as potential cholesterol-lowering agents that inhibit HMG-CoA reductase. [J Med Chem. 1985]
Isolation of compactin (a hypocholestrolemic metabolite) from a new source: Penicillium cyclopium. [J Nat Prod. 1986]
Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. [Biochim Biophys Acta. 1990]
» See all Related Articles...

Display Show